Search
Selected Filter
Displaying 1–10 of 239 research results
-
Apellis to Seek FDA Approval of its Dry AMD Drug
Known as APL-2, the drug met its primary endpoint in the OAKS clinical trial but not the DERBY trial
-
Optogenetics: Hope for Vision Restoration for Advanced Retinal Diseases
Early, encouraging results from two human studies — trials launched by Bionic Sight and GenSight — are putting optogenetic therapies in the spotlight for patients with advanced vision loss from retinal conditions.
-
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Leber Congenital Amaurosis Research Advances
Recent developments in research on Leber congenital amaurosis
-
Nanoscope Therapeutics Launches Phase 2b Clinical Trial for Optogenetic Therapy
While the trial is for people with RP, the company hopes it will also benefit people with other retinal degenerative diseases
-
The company is planning a late-stage trial for its achromatopsia (CNGB3) gene therapy.
-
Biogen’s Phase 3 Clinical Trial for its Choroideremia Gene Therapy Doesn’t Meet Endpoints
Additional results from the trial will be reported at a future scientific meeting
